Fujimoto, Shino
Kawabata, Hiroshi http://orcid.org/0000-0002-1918-8635
Sakai, Tomoyuki
Yanagisawa, Hiroto
Nishikori, Momoko
Nara, Kenji
Ohara, Shin
Tsukamoto, Norifumi
Kurose, Nozomu
Yamada, Sohsuke
Takai, Kazue
Aoki, Sadao
Masaki, Yasufumi
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (H27-28 Nanchi, etc. (Nan)- General-002; H27-Nanchi, etc. (Nan)-General-008; H29-Nanchi, etc. (Nan)-General-008; H29-Nanchi, etc. (Nan)-General-019; H29-Nanchi, etc. (Nan)-General-058, H27-Nanchi, etc. (Nan)- General-002; H27-Nanchi, etc. (Nan)-General-008; H29-Nanchi, etc. (Nan)-General-019)
Japan Society for the Promotion of Science (Grant No.17591060 and 15K09510)
Kanazawa Medical University (S2004-16, S2007-5, H2011-11, AR2012-06)
Article History
Received: 13 May 2020
Revised: 27 August 2020
Accepted: 15 September 2020
First Online: 24 September 2020
Compliance with ethical standards
:
: Dr. Kawabata reports grants from Ministry of Health, Labor, and Welfare (MHLW) of Japan, during the conduct of the study. Dr. Nishikori reports personal fees from Eisai Co., Ltd., grants from Eisai Co., Ltd., grants from Sumitomo Dainippon Pharma Co., Ltd., outside the submitted work. Dr. Tsukamoto reports scholarship donation from Kyowa Hakko Kirin Co., Ltd., outside the submitted work. Dr. Aoki reports personal fees from AbbVie GK., personal fees from Janssen Pharmaceutical K.K, outside the submitted work. Dr. Masaki reports grants from Ministry of Health, Labor, and Welfare (MHLW) of Japan, grants from Ministry of Education, Culture, Sports, Science and Technology, grants from Kanazawa Medical University, grants from Eisai Co., Ltd., grants from Kyowa Hakko Kirin Co., Ltd., grants from Astellas Pharma Inc., grants from Ono Pharmaceutical Co. Ltd., grants from Pfizer Seiyaku K. K., during the conduct of the study.